Editorial

DOI: 10.4244/EIJ-E-24-00017

Is this the end of the ultrathin-strut hypothesis?

Sripal Bangalore1, MD, MHA; Aloke V. Finn2,3, MD

From Grüntzig first coronary angioplasty to contemÂporary drug-eluting stents (DES), there has been significant progress in stent technology. A change in the biomaterial used, from stainless steel to cobalt/platinum chromium, has allowed for thinner struts while maintaining radial strength and radiopacity. The strut thickness has been reduced through the generations of thick (>100 μm), thin (70 to 100 μm) to now ultrathin DES (<70 μm)1. Preclinical models and human stented arteries demonstrate that strut thickness impacts medial injury and inflammation, leading to higher degrees of neointimal hyperplasia for thicker-strut stents. In parallel with the improvement in strut thickness, stent polymer technology evolved from durable polymers (DP) to biodegradable polymers (BP). However, BP-DES on a thin-strut platform have been at best non-inferior to current-generation DP-DES, and the promise of a late superiority (after bioabsorption of the polymer) has remained elusive2. On the other hand, clinical trials and meta-analyses have shown the superiority of ultrathin-strut DES over thin-strut DES1. The ultrathin DES have a strut thickness between 50 μm and 65 μm; they use a biodegradable polymer and elute...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 10
May 20, 2024
Volume 20 Number 10
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV16I17A251 Apr 20, 2021
To be better among the best: a difficult task
Colombo A and Mangieri A
free

EXPERT REVIEW

10.4244/EIJ-D-17-00557 Aug 25, 2017
State of the art: coronary artery stents – past, present and future
Stefanini G et al
free

10.4244/EIJV14I16A277 Mar 20, 2019
Progress with drug-eluting stents – are we done?
Capodanno D
free

10.4244/EIJV11I3A48 Jul 20, 2015
Biodegradable or biocompatible polymer drug-eluting stent: a Gordian knot
Zhang Y-J et al
free

10.4244/EIJV7I9A161 Jan 20, 2012
It’s time to say goodbye... (to the first-generation drug-eluting stent era)
Jørgensen E and Kelbæk H
free

10.4244/EIJV9I3A51 Jul 26, 2013
Polymer coatings on drug-eluting stents: Samson’s hair and Achilles’ heel?
Basalus M et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved